I have a new article, ““Getting to the table”: Changing ideas about public and patient involvement in Canadian drug assessment”
I attended the 2017 Canadian Agency for Drugs and Technologies in Health Symposium on April 24 and 25, and had
In June 2016, I was awarded a multi-year SSHRC Insight Development Grant for a project, entitled “Ideas and social policy in
The House Standing Committee on Health is currently holding hearings on a national pharmacare program. I testified on April 20;
My op-ed on why we need bold reforms to pharmacare appears in ipolitics.
Evaluating the Cost-effectiveness of Pharmaceuticals in Canada This article describes the adoption of the first Canadian Guidelines for Economic Evaluation
Dr. Danielle Martin reviews my book in the September issue of the Literary Review of Canada: read it here
Available April 6, 2015, a new book published by the University of Toronto Press that compares the policy histories of